PLx Pharma Inc. Reports Second Quarter 2018 Results
HOUSTON, Aug. 10, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on c.....»»

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018
HOUSTON, TX and VANCOUVER, Dec. 13, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSXV:EPI, NASDAQ:EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corpo.....»»
Ascendis Pharma A/S Reports Third Quarter 2018 Financial Results
Ascendis Pharma A/S Reports Third Quarter 2018 Financial Results.....»»
China Pharma Holdings, Inc. Reports Third Quarter 2018 Financial Results
HAIKOU CITY, China, Nov. 15, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE:CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully.....»»
PLx Pharma Inc. Reports Third Quarter 2018 Results
PLx has identified the alternate supply of a key ingredient for Vazalore HOUSTON, Nov. 09, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on commerciali.....»»
Ascendis Pharma A/S Reports Second Quarter 2018 Financial Results
- Continued advancement of endocrinology rare disease pipeline, paving way for application of TransCo.....»»
Intec Pharma Reports Second Quarter 2018 Financial Results and Corporate Update
Intec Pharma Reports Second Quarter 2018 Financial Results and Corporate Update Enrolled more than 95% of .....»»
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2018
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fisca.....»»
PLx Pharma Inc. Reports Second Quarter 2018 Results
HOUSTON, Aug. 10, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on c.....»»
ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance
ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance Acquires WellSpring Pharma Services for $18 Million in Cash to Expand Contract Manufacturing Business and Accelerate ANDA Pipeline .....»»
Madrigal Pharmaceuticals Reports 2018 Second Quarter Financial Results and Reviews Key Clinical Achievements
CONSHOHOCKEN, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharma.....»»
Ascendis Pharma A/S Reports First Quarter 2018 Financial Results
- Continued.....»»
Intec Pharma Reports First Quarter 2018 Financial Results and Corporate Update
Intec Pharma Reports First Quarter 2018 Financial Results and Corporate Update More than 350 patients enrolled in pivotal Phase 3 A.....»»
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2018
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fisc.....»»
Evoke Pharma Reports First Quarter 2018 Results and Highlights
NDA submission for Gimoti™ on track for second quarter of 2018 Announced.....»»
PLx Pharma Inc. Reports First Quarter 2018 Results
HOUSTON, May 11, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceu.....»»
MEI Pharma Reports Third Quarter Fiscal Year 2018 Results
MEI Pharma Reports Third Quarter Fiscal Y.....»»
Recro Pharma Reports First Quarter 2018 Financial Results
Recro Pharma Reports First Quarter 2018 Financial Results.....»»
Hollysys Automation Technologies Reports Unaudited Financial Results for the Second Quarter and the First Half Year Ended December 31, 2018
First Half Year of Fiscal Year 2019 Financial Highlights Non-GAAP net income attributable to Hollysys was $72.4 million, an increase of 24.3% co.....»»
FHLB Des Moines Reports 2018 Preliminary Unaudited Financial Results and Fourth Quarter 2018 Dividend
DES MOINES, Iowa, Feb. 15, 2019 (GLOBE NEWSW.....»»
ORYZON Reports Financial Results and Corporate Update for the 4th Quarter and Year Ended December 31, 2018
-$0.04/share for the 12.....»»